School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Drug Des Devel Ther. 2022 Jun 7;16:1731-1741. doi: 10.2147/DDDT.S365292. eCollection 2022.
Tumor-associated anorexia, mainly including cancerous anorexia and chemotherapy-induced anorexia, severely reduces the life quality of cancer patients but lacks of effective control until now. Liujunzi decoction (LJZD), a classical tonifying formula in traditional Chinese medicine, has promising effect in preventing and treating many kinds of anorexia. A growing number of evidence showed that LJZD is able to improve tumor-associated anorexia. Up to March 2022, a total of 58 articles studying LJZD or Rikkunshito (the name of LJZD in Japanese herbal medicine) in the treatment of tumor-associated anorexia are searched out in PubMed. This paper summarizes the effect of LJZD in ameliorating tumor-associated anorexia, in order to provide a theoretical basis for the clinical application of LJZD in treating tumor-associated anorexia, laying foundation for further research.
肿瘤相关性厌食症,主要包括癌性厌食症和化疗相关性厌食症,严重降低了癌症患者的生活质量,但至今缺乏有效的控制手段。六君子汤(LJZD)是一种经典的中药滋补方,在预防和治疗多种厌食症方面具有良好的效果。越来越多的证据表明,LJZD 能够改善肿瘤相关性厌食症。截至 2022 年 3 月,在 PubMed 上共检索到 58 篇关于 LJZD 或六君子汤(LJZD 的日本草药名称)治疗肿瘤相关性厌食症的研究文章。本文总结了 LJZD 改善肿瘤相关性厌食症的作用,以期为 LJZD 治疗肿瘤相关性厌食症的临床应用提供理论依据,为进一步研究奠定基础。